Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Don’t Mind Insiders, They’re Just Busy Accumulating Shares Of Alico, Inc. (ALCO)

The $182.5 million of fixed-rate and floating-rate net debt that Alico took to finance the acquisitions is reasonable. According to management, the weighted cost of debt is 3.5% and the duration is 15 years. Alico has plenty of interest coverage for the debt, with an EBITDA to interest expense of 6.9x. Management paid off $11.3 million of debt during its fiscal second quarter, giving the company a net debt of $229.2 million at the end of that quarter. So far, Alico’s adjusted EBITDA has not matched management’s expectations. For the fiscal second quarter, Alico reported an adjusted EBITDA of $15.7 million, an increase from 2014’s second quarter EBITDA of $10.7 million, but nowhere near the tripling that management expected. One reason for the lower than expected adjusted EBITDA was lower citrus prices, which fell 6.8% year-over-year.

Alico, Inc. (NASDAQ:ALCO) would be a good investment at $45 per share. At that price, Alico would trade at a P/FCF of 13.6, giving the company an owner’s earnings yield of 7.5%. Assuming that a citrus blight doesn’t destroy Alico’s harvest and that citrus prices keep up with inflation, shareholders would have an additional 3% annual return.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.